000			01631 a2200493 4500
005			20250513085653.0
264		0	_c19960423
008			199604s 0 0 eng d
022			_a0022-1767
040			_aNLM _beng _cNLM
100	1		_aDan, Y
245	0	0	_aIL-3 augments TCR-mediated responses of type 2 CD4 T cells. _h[electronic resource]
260			_bJournal of immunology (Baltimore, Md. : 1950) _cJan 1996
300			_a27-34 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdjuvants, Immunologic _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntigens _ximmunology
650	0	4	_aBinding, Competitive
650	0	4	_aCalmodulin _xphysiology
650	0	4	_aClone Cells
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aInterleukin-1 _xpharmacology
650	0	4	_aInterleukin-3 _ximmunology
650	0	4	_aInterleukin-4 _xbiosynthesis
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, Inbred C3H
650	0	4	_aMice, Inbred C57BL
650	0	4	_aReceptors, Antigen, T-Cell _xdrug effects
650	0	4	_aReceptors, Interleukin-3 _xmetabolism
650	0	4	_aSignal Transduction _ximmunology
650	0	4	_aSpleen
650	0	4	_aTacrolimus _xpharmacology
650	0	4	_aTh1 Cells _xdrug effects
650	0	4	_aTh2 Cells _xdrug effects
700	1		_aKatakura, Y
700	1		_aAmetani, A
700	1		_aKaminogawa, S
700	1		_aAsano, Y
773	0		_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 156 _gno. 1 _gp. 27-34
999			_c8597522 _d8597522